arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Accustem Sciences Inc.

ACUT

— Price unavailable

22 Visible periods

18 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Bullish

auto_awesome

Analytical Summary

Accustem Sciences Inc. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap —

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC 9.9% ↘

FCF / Share $-0.02

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close.

22-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-485.88K

↓ -10.3% —

FCF / Share Free cash flow per share

$-0.02

↓ -2.1% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Returns

Financial Health ↓

Cash Quality →

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
EPS Growth YoY (%)	0.0% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	-33.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	33.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	40.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-50.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	40.0% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	33.3% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	28.6% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	77.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	37.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	70.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	12.5% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-50.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-700.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-900.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—
Net Income Growth YoY (%)	-10.3% Weak ↑ Weak Improving Year-over-year change in net income	-38.2% Weak ↓ Weak Declining Year-over-year change in net income	-21.9% Weak ↑ Weak Improving Year-over-year change in net income	-44.3% Weak ↓ Weak Declining Year-over-year change in net income	16.4% Good ↑ Good Improving Year-over-year change in net income	-51.2% Weak ↓ Weak Declining Year-over-year change in net income	45.2% Excellent → Excellent Stable Year-over-year change in net income	25.4% Excellent ↓ Excellent Declining Year-over-year change in net income	36.8% Excellent ↓ Excellent Declining Year-over-year change in net income	74.9% Excellent ↑ Excellent Improving Year-over-year change in net income	33.4% Excellent ↑ Excellent Improving Year-over-year change in net income	65.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-5.4% Weak ↑ Weak Improving Year-over-year change in net income	-80.0% Weak ↑ Weak Improving Year-over-year change in net income	-1333.5% Weak ↑ Weak Improving Year-over-year change in net income	-2033.5% Weak Weak Year-over-year change in net income	-5598.4% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	-2.1% Weak Weak Year-over-year change in free cash flow	—	—	—	-9.0% Weak Weak Year-over-year change in free cash flow	—	—	—	46.8% Excellent Excellent Year-over-year change in free cash flow	—	—	—	N/M	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
FCF / Net Income (x)	0.77x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	-0.04x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.51x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-0.05x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.66x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-0.00x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.45x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.20x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	0.54x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.64x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	-0.46x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Return on Invested Capital (%)	9.9% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	11.9% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	10.9% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	12.5% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	16.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	8.9% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	8.1% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	7.6% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	15.9% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	9.2% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	25.1% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	22.5% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	69.5% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	554.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-89.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-51.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-23.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-66.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-0.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-31.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-33.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-25.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-24.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-28.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-731.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-316.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-199.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-1033.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-183.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-232.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-81.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-336.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-104.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-55.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-45.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-24.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-40.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	12.5% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-16%)	15.1% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	13.7% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-8%)	15.8% Good ↑ Good Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+6%)	20.4% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+36%)	11.2% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-25%)	10.3% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-31%)	9.6% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-36%)	20.1% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+34%)	11.7% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-22%)	31.7% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+112%)	28.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+90%)	88.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+487%)	—	-112.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-851%)	-65.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-535%)	-29.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-296%)	-83.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-657%)	-5.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-135%)	-4.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-127%)	-1.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-107%)	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Interest Coverage (x)	-1446.08x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-372.34x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-904.06x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-1310.74x Weak Weak Operating income divided by interest expense Optimal: > 5x	-447.24x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-755.53x Weak Weak Operating income divided by interest expense Optimal: > 5x	-84.43x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-1187.10x Weak Weak Operating income divided by interest expense Optimal: > 5x	-559.80x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Basic EPS, GAAP (USD)	$-0.03	$-0.04	$-0.02	$-0.02	$-0.03	$-0.03	$-0.03	$-0.02	$-0.05	$-0.02	$-0.05	$-0.03	$-0.07	$-0.09	$-0.08	$-0.10	$-0.08	$-0.06	$-0.01	$-0.01	$0.00	—
Free Cash Flow per Share (USD)	$-0.02	—	$-0.04	$0.00	$-0.02	—	—	—	$-0.02	—	—	—	$-0.04	—	—	—	$0.04	—	—	—	—	—
Book Value per Share (USD)	$-0.24	$-0.21	$-0.18	$-0.16	$-0.13	$-0.27	$-0.28	$-0.25	$-0.23	$-0.19	$-0.17	$-0.12	$-0.08	$-0.01	$0.07	$0.15	$0.24	$0.07	$0.12	$0.13	$0.13	—
Tangible Book Value per Share (USD)	$-0.24	$-0.21	$-0.18	$-0.16	$-0.13	$-0.27	$-0.28	$-0.25	$-0.23	$-0.19	$-0.17	$-0.12	$-0.08	$-0.01	$0.07	$0.15	$0.24	$0.07	$0.12	$0.13	$0.13	—
Basic Weighted Avg Shares (shares)	16.07M	—	16.07M	16.07M	12.72M	—	11.35M	11.35M	11.35M	—	11.35M	11.35M	11.35M	—	11.34M	11.34M	10.03M	—	10.00M	10.00M	10.00M	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Working Capital (USD)	$-5.37M	$-4.90M	$-2.91M	$-2.53M	$-2.16M	$-3.31M	$-3.19M	$-2.89M	$-2.62M	$-2.12M	$-1.89M	$-1.31M	$-953.45K	$-147.23K	$789.14K	$1.64M	$2.68M	$650.67K	—	—	—	—
Total Equity (USD)	$-3.87M	$-3.40M	$-2.91M	$-2.53M	$-2.16M	$-3.31M	$-3.19M	$-2.88M	$-2.62M	$-2.11M	$-1.89M	$-1.31M	$-946.68K	$-139.55K	$797.72K	$1.65M	$2.69M	$650.67K	$1.19M	$1.26M	$1.31M	$1.31M

📋 What is driving earnings? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Depreciation Expense (USD)	—	$0.00	$0.00	$105.00	$313.00	$907.00	$907.00	$907.00	$908.00	$907.00	$907.00	$907.00	$908.00	$907.00	$907.00	$830.00	$677.00	—	$0.00	$0.00	—	—
Net Income, GAAP (USD)	$-485.88K	$-514.39K	$-399.90K	$-401.40K	$-440.41K	$-372.10K	$-328.17K	$-278.23K	$-526.60K	$-246.04K	$-598.52K	$-372.76K	$-833.34K	$-978.53K	$-899.12K	$-1.08M	$-790.53K	$-543.48K	$-62.72K	$-50.54K	$-13.87K	—
Operating Cash Flow (USD)	$-374.18K	$22.36K	$-604.13K	$21.57K	$-290.18K	$414.00	—	—	$-237.35K	$-295.03K	—	—	$-446.09K	$-622.26K	—	—	$371.98K	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 6 years · 22 quarters

Accustem Sciences Inc.

Analytical Summary

22-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ACUT with peers